BioSpace News Archive

Policy

March Of Dimes Praises Passage Of S. 3029, The PREEMIE Reauthorization Act Of 2018

March of Dimes hailed U.S. Senate passage today of S. 3029, the PREEMIE Reauthorization Act of 2018, a bill to renew key laws aimed at preventing and treating preterm birth and its complications.

September 12, 2018
·
2 min read
BioForest

New Data: Adult Obesity Rates Top 35 Percent in Seven States, No State Obesity Rate Improved Significantly During the Past Year

Report emphasizes urgent need to increase evidence-based obesity prevention programs to prevent disease and potentially save billions in healthcare spending

September 12, 2018
·
7 min read
Policy

U.S. Department of Defense Awards $3.3 Million Grant to Alivio Therapeutics

Research award will support preclinical activities to advance product candidate for the treatment of interstitial cystitis/bladder pain syndrome into the clinic

September 12, 2018
·
6 min read
Drug Development

Bristol-Myers Squibb’s Novel, Oral, Selective TYK2 Inhibitor Delivered Significant Skin Clearance in Patients with Moderate to Severe Plaque Psoriasis in Phase 2 Trial

Efficacy endpoints including ≥75% and 90% reduction in the Psoriasis Area and Severity Index (PASI 75, PASI 90) were achieved following 12 weeks of treatment with ≥3 mg daily of BMS-986165

September 12, 2018
·
6 min read
Business

Systech Announces Partnership with FarmaTrust to Deliver Foolproof Pharmaceutical Blockchain Solution

Revolutionary solution provides authentic, safe and connected products throughout the pharmaceutical supply chain

September 12, 2018
·
2 min read
Policy

Biohaven Announces Submission of IND for BHV-3500, Third-Generation, Small Molecule CGRP-Receptor Antagonist for the Treatment of Migraine

BHV-3500 is the first intranasal formulation of a small molecule calcitonin gene-related peptide receptor antagonist to be advanced for human dosing in clinical trials.

September 12, 2018
·
7 min read
Pharm Country

Exude Launches a New Benefits Product

Exude, Inc. expands its employee benefit offerings through a new program, Exude Solution Builder.

September 12, 2018
·
1 min read
Deals

Shore Capital Partners Announces Acquisition of Eagle Laboratories

Shore Capital Partners, LLC (“Shore Capital” or “Shore”) is pleased to announce that Innovia Medical (“Innovia”), its specialty surgical products platform, has partnered with Eagle Laboratories (“Eagle Labs”).

September 12, 2018
·
3 min read
Job Trends

Systems Oncology Announces the ExpansiveAI Project to Advance Artificial Intelligence Capable of Imagination

Dr. Spyro Mousses, CEO of Systems Oncology, LLC, announced the launch of the ExpansiveAI project today at the AIMed Conference in London, UK

September 12, 2018
·
2 min read
FDA

FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Monotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer in Patients Whose Tumors Express PD-L1 (TPS ≥1%)

Application Based on Overall Survival Data from Pivotal Phase 3 KEYNOTE-042 Trial

September 12, 2018
·
24 min read